MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字HJ20200062

December 25, 2020

Drug Information

盐酸奥洛他定滴眼液

帕坦洛

滴眼剂

0.2%(2.5ml:5mg,按C21H23NO3计)

化学药品

December 25, 2020

December 24, 2025

Company Information

Applicant Company

20 Pasir Panjang Road #10-25/28 Mapletree Business City Singapore 117439

Manufacturing Company

6201 South Freeway,Fort Worth, TX 76134 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定滴眼液 - NMPA 批准文号 | MedPath